2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on NSCLC: Neoadjuvant Chemo for Locally Advanced Disease, Gefitinib vs Chemo for EGFR+ NSCLC & Adjuvant Osimertinib ‘Practice Changing’ for Early-Stage EGFR Mutated NSCLC

95 views
July 15, 2020
Comments 0
Login to view comments. Click here to Login